# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-097073
Filing Date
2024-08-14
Accepted
2024-08-14 16:25:15
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | pyxs-20240630.htm iXBRL | 10-Q | 2057114
2 | EX-10.1 | pyxs-ex10_1.htm | EX-10.1 | 115059
3 | EX-31.1 | pyxs-ex31_1.htm | EX-31.1 | 14803
4 | EX-31.2 | pyxs-ex31_2.htm | EX-31.2 | 14808
5 | EX-32.1 | pyxs-ex32_1.htm | EX-32.1 | 8675
6 | EX-32.2 | pyxs-ex32_2.htm | EX-32.2 | 8032
7 | GRAPHIC | img32422092_0.jpg | GRAPHIC | 122064
| Complete submission text file | 0000950170-24-097073.txt |  | 7791960

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pyxs-20240630.xsd | EX-101.SCH | 1322824
67 | EXTRACTED XBRL INSTANCE DOCUMENT | pyxs-20240630_htm.xml | XML | 917104

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40881 | Film No.: 241208423
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)